These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Therapeutic indications in oncology: emerging features and regulatory dynamics. Tafuri G; Leufkens HG; Laing R; Trotta F Eur J Cancer; 2010 Feb; 46(3):471-5. PubMed ID: 20056536 [TBL] [Abstract][Full Text] [Related]
44. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions. Hayman JN; Sbravati EC Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250 [TBL] [Abstract][Full Text] [Related]
45. Biowarfare lab approved without restrictions. Smith RJ Science; 1984 Dec; 226(4681):1405. PubMed ID: 17788988 [No Abstract] [Full Text] [Related]
46. Proteolytic systems of lactic acid bacteria. Savijoki K; Ingmer H; Varmanen P Appl Microbiol Biotechnol; 2006 Jul; 71(4):394-406. PubMed ID: 16628446 [TBL] [Abstract][Full Text] [Related]
47. Viral vectors for use in the development of biodefense vaccines. Lee JS; Hadjipanayis AG; Parker MD Adv Drug Deliv Rev; 2005 Jun; 57(9):1293-314. PubMed ID: 15935875 [TBL] [Abstract][Full Text] [Related]
48. Are postural restrictions after an Epley maneuver unnecessary? First results of a controlled study and review of the literature. Fyrmpas G; Rachovitsas D; Haidich AB; Constantinidis J; Triaridis S; Vital V; Tsalighopoulos M Auris Nasus Larynx; 2009 Dec; 36(6):637-43. PubMed ID: 19410397 [TBL] [Abstract][Full Text] [Related]
49. The economic impact of state restrictions on abortion: parental consent and notification laws and Medicaid funding restrictions. Haas-Wilson D J Policy Anal Manage; 1993; 12(3):498-511. PubMed ID: 10127357 [TBL] [Abstract][Full Text] [Related]